Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy 1C (LGMD1C). However, the precise molecular pathogenesis of caveolin-3-related muscular dystrophy remains uncertain. Here, we demonstrate the effect of gene dosage on the severity of the myopathic phenotype in P104L mutant caveolin-3 (mCav3 P104L ) transgenic mice, a model of LGMD1C. We analyzed the endoplasmic reticulum (ER) stress response in the transgenic mice and found upregulated transcription of the molecular chaperone, glucose-regulated protein (GRP78). Moreover, signaling downstream of GRP78 in the myofibers was activated toward apoptosis. However, terminal transferase dUTP nick end labeling assays detected a few apoptotic nuclei in transgenic mouse skeletal muscle, probably due to the transcriptional activation of Dad1, an anti-apoptotic factor in the ER. These findings suggest that the ER stress response caused by mCav3 P104L plays a role in the pathogenesis of LGMD1C as a toxic gain of function effect.
INTRODUCTION
Caveolae are characterized as flask-shaped invaginations of the plasma membrane (1). Caveolin is a major structural component of caveolae (2) and it also functions as a scaffolding protein to concentrate and regulate many classes of signaling molecules. Distinct genes encode the isoforms, caveolin-1, -2 and -3. Caveolin-3 is specifically expressed in muscle cells (3) . Co-expressed caveolins-1 and -2 form heterooligomers in non-muscle cells, whereas caveolin-3 forms homo-oligomers in muscle cells. Different mutations in the human caveolin-3 gene have been associated with several muscle diseases that are collectively called caveolinopathies and include limb-girdle muscular dystrophy, distal myopathy and rippling muscle disease (4, 5) . A mutant caveolin-3 with a single amino acid substitution from proline to leucine at amino acid residue 104 (mCav3 P104L ) was originally identified from a genetic analysis of autosomal dominant limb-girdle muscular dystrophy 1C (LGMD1C) (6) .
Since LGMD1C is inherited as an autosomal dominant trait, mCav3 P104L presumably has a dominant-negative effect on the molecular pathogenesis of caveolinopathy. Studies in vitro have shown that homo-oligomers of wild-type caveolin-3 translocate to the cell membrane via the endoplasmic reticulum (ER)-Golgi network, whereas mCav3 P104L does not target the cell membrane (7) . The hetero-oligomers formed between wildtype caveolin-3 and mCav3 P104L in the ER-Golgi system are degraded by the ubiquitin-proteasome proteolytic pathway, which might lead to the loss of caveolin-3 in LGMD1C (7, 8) . Targeted downregulation of caveolin-3 gene in differentiating C2C12 myoblasts can inhibit myotube formation (9) . Expression of mCav3 P104L can trigger a loss of caveolin-3 during C2C12 cell differentiation (10) . These results suggest that the secondary loss of caveolin-3 due to mCav3 P104L is associated with the molecular pathology of LGMD1C. However, whether mCav3 P104L has a gain of function effect that contributes to the pathogenesis of LGMD1C remains uncertain. The ER stress response to the accumulation of a mutant protein has recently garnered interest among those investigating the pathogenesis of neurodegenerative disorders. For instance, the cytoplasmic aggregation of alpha-synuclein that is a pathological hallmark of Parkinson's disease is accelerated in a form of familial Parkinson's disease caused by a dominant mutation of the alpha-synuclein gene (11 May 24, 2011 are involved in the ER-associated ubiquitination system (12) . However, the ER stress response has not been intensively studied from the viewpoint of muscular dystrophy. We previously generated and studied mCav3 P104L transgenic mice as a model of LGMD1C (13) (14) (15) . The present study investigates the ER stress response in mCav3 P104L transgenic mice as well as a possible gain of function effect of mCav3 P104L .
RESULTS

Dose effect of mCav3
P104L transgene on the severity of the myopathic phenotype
We previously identified a severe myopathic phenotype in mCav3 P104L hemizygous transgenic mice (13) . Homozygous mCav3 P104L mice were obtained by hemizygous intercrossing and southern blot analysis confirmed the wild-type, hemizygous and homozygous transgenic mouse genotypes (Fig. 1A) . Western blot analysis detected less caveolin-3 protein in hemizygous than in homozygous mice (Fig. 1B) . We then analyzed the effect of mCav3 P104L gene dosages on the myopathic phenotype. Consistent with our previous findings (13) , hemizygous mice weighed less than wild-type mice, but the difference did not reach statistical significance. The difference in body weight between homozygous and wildtype mice was statistically confirmed from 4 and 12 weeks of age at all measured points (Fig. 1C) . We also found that grip strength significantly differed between the groups from 4 and 12 weeks of age at most measured points (Fig. 1D) . Central nucleation or mononuclear infiltration was essentially absent. We measured average areas of myofibers in quadriceps muscles from mice of each genotype (Fig. 1E) . Small myofibers were more frequent in the order of homozygous . hemizygous . wild-type mice and non-parametrical statistical analysis confirmed significant differences among the groups (Fig. 1F) . The frequency of small myofibers in the gastrocnemius muscle also significantly differed among the genotypes (Supplementary Material, Fig. S1A and B). These data showed that the dose of the mCav3 P104L transgene correlated with the severity of the myopathic phenotype.
Residual level of caveolin-3 protein and the myopathic phenotype
The residual amount of caveolin-3 protein in mCav3 P104L transgenic mice was ,20% of that in wild-type mice (Fig. 1B) . To confirm whether other caveolin isoforms counteract the loss of caveolin-3 in muscle cells, we analyzed the expression of caveolin-1 and -2 in mCav3 P104L transgenic mice. Messenger RNA levels of caveolin-1 and -2 were increased about 1.5-fold in the skeletal muscle of homozygous mice, whereas no significant change was detectable in hemizygous mice ( Fig. 2A and B) . Western blotting showed that these changes were consistent at the protein level ( Fig. 2C and D) . However, immunohistochemistry revealed that upregulated caveolins-1 and -2 were not localized to the sarcolemma, but to the muscle interstitial region containing blood vessels (Fig. 2E) . These results indicated that caveolin-1 and -2 upregulation does not compensate for the lack of caveolin-3 function in skeletal muscle. Interestingly, less caveolin-3 protein was detected in hemizygous than in homozygous mice (Fig. 1B) . Since the antibodies used for western blotting cannot distinguish between endogenous and mutant caveolin-3 protein, these results suggest that the increased amount of residual mCav3 P104L protein in homozygous mice led to more severe myopathy via a toxic gain of function effect.
Localization of mCav3
P104L protein and ER stress response
We investigated the subcellular localization of mCav3 P104L in vitro. Cosmids containing a fluorescent marker for the ER (DsRed-KDEL) or for the Golgi complex (DsRed-Golgi) were cotransfected with wild-type caveolin-3 or mCav3 P104L into C2C12 myoblasts. Immunostaining showed surface membrane localization of wild-type caveolin-3, whereas mCAV3 P104L did not target the surface membrane and tended to colocalize with the Golgi, but not the ER marker (Fig. 3) . The Golgi marker and mCAV3 P104L also colocalized in COS7 cells (Supplementary Material, Fig. S2 ).
We investigated whether mCav3 P104L in muscle cells could induce the ER stress response in mCav3 P104L transgenic mice by analyzing the expression of genes related to ER stress. Messenger RNA levels of glucose-regulated protein (GRP78), a molecular chaperone in the ER (16), increased 1.5-and 2.5-fold in hemizygous and homozygous mice, respectively, compared with wild-type mice ( Fig. 4A and C) . Western blotting also confirmed GRP78 induction at the protein level ( Fig. 4B and D) . Eukaryotic initiation factor 2a (eIF2a) is phosphorylated in response to GRP78 induction under ER stress (17, 18) . Although the total amount of eIF2a did not significantly change, the amount of phosphorylated eIF2a was increased in transgenic compared with wild-type mice ( Fig. 4B and E) . We then evaluated the mRNA levels of C/EBP homologous protein (CHOP), which is a preapoptotic transcription factor that functions downstream of phosphorylated eIF2a (18, 19) , and found that they were significantly increased in mCav3 P104L transgenic mice ( Fig. 4A  and C) . Overall, these results suggested that mCav3 P104L accumulates in the Golgi complex and induces the ER stress response mediated by the molecular chaperone GRP78 and its downstream pathway.
ER stress response toward apoptosis in myofibers from mCav3 P104L transgenic mice
We compared the consequences of the mCav3 P104L -induced ER stress response using terminal transferase dUTP nick end labeling (TUNEL) assays of quadriceps muscles from mCav3 P104L transgenic mice and other mouse models of muscular dystrophy, namely mdx and dy mice (Fig. 5A) . Several TUNEL-positive nuclei of interstitial cells were located outside the myofibers of mdx mice and dy mice. To distinguish these cells from apoptotic myofibers, we counted the number of myofibers with TUNEL-positive nuclei. Unlike mdx mice and dy mice, TUNEL-positive nuclei in mCav3 P104L transgenic mice were mainly located inside myofibers. Although the average number of TUNEL-positive myofibers was increased in mCav3 P104L transgenic mice, the increase was modest compared with the amount in mdx mice and dy mice (Fig. 5B) .
2976
Human Molecular Genetics, 2011, Vol. 20, No. 15
We immunohistochemically analyzed cleaved caspase-3 and cytochrome c to further elucidate the ER stress response toward apoptosis in myofibers. Caspase-3 is activated by proteolysis in the signaling cascade toward apoptosis (20) . Cleaved caspase-3, which is an active form of caspase-3, is increased in response not only to ER stress but also to P104L transgenic mice. Levels of caveolin-3 protein obviously decreased in the transgenic mice. Residual caveolin-3 was detected in homozygous mice. Temporal changes in body weight (C) and grip strength (D) of wild-type and transgenic mice between 4 and 12 weeks of age (n ¼ 5 per group). Differences within each group were statistically determined using Scheffe's test.
* Significant difference between wild-type and homozygous mice (P , 0.05). † Significant difference between each group (P , 0.05). Bars indicate standard error. (E) Histograms of individual myofiber areas in quadriceps muscle on transverse sections. Values were determined from 1000 myofibers per group. Bar ¼ 100 mm. (F) Box plot represents non-parametric statistical analysis of myofiber areas of each group in (E). Significant difference between two groups (Mann-Whitney U test, * P , 0.005).
Human
apoptotic signals from the mitochondria (20, 21) . On the other hand, mitochondria specifically release cytochrome c into the cytosol under the latter conditions (20, 22) . Immunoreactivity for cleaved caspase-3 was obvious in the subsarcolemmal area of myofibers in mCav3 P104L transgenic mice (Fig. 5A ). The average number of cleaved caspase-3 positive myofibers was increased in mCav3 P104L transgenic mice and differences between each genotype were significant (Fig. 5C ). Cytochrome c-positive myofibers were rare in mCav3 P104L transgenic mice. Immunostained cleaved caspase-3 covered the entire area of myofibers that were frequently cytochrome c-positive in mdx and dy, but not in mCav3 P104L transgenic mice (Fig. 5A) .
Apoptotic changes in myofibers were modest in mCav3 P104L transgenic mice compared with mdx or dy mice. We examined the expression of anti-apoptotic molecules from this perspective and found that Dad1 mRNA was upregulated in mCav3 P104L transgenic mice ( Fig. 6A and B) . Dad1 is a subunit of the oligosaccharyl transferase complex that catalyzes the glycosylation of misfolded proteins to reduce ER stress (23, 24) . The upregulation of Dad1 might contribute to the reduction of apoptosis in mCav3 P104L transgenic mice. 
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DISCUSSION
Mutations of the caveolin-3 gene cause LGMD with an autosomal dominant inheritance (6) . Despite numerous studies in vitro using the disease-generating P104L mutant caveolin-3 (7 -10), details of the molecular pathogenesis underlying
LGMD1C have not been fully elucidated. Immunostaining for caveolin-3 at the sarcolemma is obviously lost in patients with LGMD1C (5,6). Galbiati's group proposed a dominantnegative effect of mutant caveolin-3 and demonstrated that it forms unstable aggregates of caveolin-3 hetero-oligomers with wild-type caveolin-3 that are retained in the Golgi complex (7) and that they are likely to be degraded by the ubiquitin -proteasome system (8) . These data can explain why caveolin-3 protein levels were reduced in patients with LGMD1C. However, myopathy was notably milder in caveolin-3-null mice (25) , but more severe in mCav3 P104L transgenic mice (13) . Thus, a loss of caveolin-3 caused by the dominant-negative mechanism does not simply account for the severity of the disease in mice. A mechanism other than the reduced expression of caveolin-3 protein might function in the molecular pathogenesis of LGMD1C. Here, we investigated phenotypic differences between hemizygous and homozygous mCAV3 P104L transgenic mice from morphological and molecular aspects. Myofiber hypotrophy and muscular weakness were more prominent in homozygous than in hemizygous mice. These findings indicated that the dosage of the mutant caveolin-3 transgene correlates with the severity of the myopathic phenotype. However, the lower level of residual caveolin-3 protein in hemizygous than in homozygous muscles is curious. This finding suggests that the level of mutant caveolin-3 determines the severity of myopathy through a toxic gain of function effect.
A unique feature of human LGMD1C is subsarcolemmal Golgi accumulation (possibly sarcoplasmic bodies) (5). The present and other studies have demonstrated mCav3 P104L accumulation in the Golgi apparatus in vitro (7, 8, 26) . Previous pulse-chase experiments revealed that wild-type caveolin forms oligomers of about 400 kDa soon after the protein is synthesized in the ER (27) . In addition, the mCav3 P104L proteins retained in the Golgi are composed of over 400 kDa high-molecular aggregates, and a proteasomal inhibitor causes such aggregates to accumulate within the ER (8) . Together, newly synthesized mutant caveolin-3 protein could rapidly form misfolded aggregates in the ER, thereby inducing the ER stress response. Therefore, we analyzed the ER stress response to investigate a toxic gain of function effect of mCav3 P104L . Indeed, we found that mCAV3 P104L induces the ER stress response in a gene-dose-dependent manner. Transcription of the molecular chaperone GRP78 was upregulated in mCav3 P104L transgenic mice. Under normal conditions, GRP78 suppresses the ER stress signaling pathway through direct interaction with ER stress transducers, such as PERK (16), which is a serine/threonine kinase that phosphorylates eIF2a (17, 18) . Misfolded proteins in the ER enlist GRP78 as a molecular chaperone. Once released from GRP78, the ER stress transducers trigger the cascade of gene regulation, known as the unfolded protein response (UPR). Molecular chaperones are commonly activated transcriptionally in the UPR (16) . The phosphorylation of eIF2a by PERK is a crucial step in the UPR (17, 18) . We showed here that these molecular events occur in the skeletal muscle of mCav3 P104L transgenic mice, although PERK kinase activity was not directly demonstrated.
We also found that anti-apoptotic Dad1 (23, 24) together with pro-apoptotic CHOP (18, 19) is gene-dose dependently upregulated in mCAV3 P104L transgenic mice. This finding may be consistent with the limited numbers of TUNEL-positive myonuclei and cleaved caspase-3-positive myofibers in mCAV3 P104L transgenic mice compared with mdx or dy mice. Dystrophic changes such as necrotic/regenerating fibers or central nucleation are rarely observed and obvious myofiber hypotrophy is the most prominent feature of mCav3 P104L transgenic mice. Transgenic mice weigh less than wild-type mice by 4 weeks of age, which suggests the absence of normal hypertrophic growth or hypoplasia of the skeletal muscle. The most recent findings in vitro have revealed that the stable mCav3 P104L expression delays myoblast fusion (26) . Therefore, the predominant small myofibers might be the result of impaired myotube formation rather than apoptosis. Overall, our results indicate that the apoptotic signaling in response to ER stress is counteracted by anti-apoptotic signaling in myofibers of mCav3 P104L transgenic mice, and that its contribution to myopathic change may be modest.
In conclusion, we demonstrated that mutant caveolin-3 dose-dependently induces the ER stress response, which would be a toxic gain of function effect related to the pathophysiology of LGMD1C. P104L combined with a fluorescent marker that specifically localizes to ER or Golgi. Wild-type caveolin-3 (upper panels) and mCav3 P104L (lower panels) recognized by anti-FLAG tag antibody are shown in green. DsRed-Golgi marker (left panels) and DsRed-ER marker (right panels) recognized by anti-DsRed antibody are shown in red.
MATERIALS AND METHODS
Animals
Mice were aged about 12 weeks in this study. The construct for the generation of mCav3 P104L transgenic mice has been described (13, 14) . All animal experiments proceeded at the Laboratory Animal Center under the approval of the Animal Research Committee of Kawasaki Medical School.
Muscle morphology and immunohistochemistry
Unfixed distal hindlimb muscles were snap-frozen in liquid nitrogen-cooled isopentane and sectioned transversely (10 mm) at the center of tibialis anterior (or quadriceps) muscle using a cryostat (Leica Microsystems). Sections were post-fixed in cold methanol for 10 min, and then immunostained using the Mouse on Mouse Kit (Vector Laboratories) according to the manufacturer's recommendations. The primary antibodies were as follows: rabbit polyclonal anti-caveolin-1 (BD Transduction Laboratories), mouse monoclonal anti-caveolin-2 (BD Transduction Laboratories), rabbit polyclonal anti-caveolin-3 (Alexis Corporation), rabbit polyclonal anti-cleaved caspase-3 (Cell Signaling Technology), anti cytochrome c (eBioscience) and rat monoclonal anti-laminin a2 (Alexis Corporation). Secondary antibodies were conjugated with fluorescein isothiocyanate.
Cell staining
C2C12 and COS7 cells were cultured on coverslips treated with the FuGENE6 transfection reagent (Roche) and then cotransfected with a caveolin-3-FLAG vector or an vector and pDsRed-Golgi (Clontech) or pCS2-DsRed-KDEL (a gift from Dr S. Nishimatsu). Twelve hours later, the cells were fixed in phosphate-buffered saline (PBS) containing 4% paraformaldehyde for 15 min and then permeabilized with PBS containing 0.5% Triton X-100 for 15 min. Non-specific binding was blocked with 3% bovine serum albumin in PBS containing 0.5% Triton X-100 for 1 h at room temperature. Cells were incubated with an anti-FLAG antibody (Sigma) and an anti-DsRed antibody (Clontech) at 48C, followed by a secondary antibody.
TUNEL assay
Cryosections of quadriceps muscles (10 mm) were fixed with 1% paraformaldehyde in PBS for 10 min at room temperature. The sections were then post-fixed in ethanol:acetic acid (2:1) for 5 min at 2208C, labeled with digoxigenin-conjugated dNTP via the enzymatic activity of terminal deoxynucleotidyl transferase and reacted with anti-digoxigenin fluorescein antibody according to the manufacturer's recommendations (Chemicon). TUNEL-positive nuclei were counted in photographs of 15 sections from each sample.
RT-PCR
We reverse-transcribed cDNA templates from RNAs extracted from C2C12 cells. Genes were amplified using the following respective forward and reverse primers: caveolin- 
Northern blot analysis
The RT-PCR products of mouse cDNAs were subcloned into pCRII-TOPO (Invitrogen) and then digested with EcoRI. The digest was separated by agarose gel electrophoresis and extracted using the Rapid Gel Extraction System (Marligen Bioscience). Fragments of DNA were then labeled with [a-32 P]-dCTP using the MegaPrime DNA Labeling System (GE Healthcare) and RNAs were extracted from the skeletal muscles of mice in each genotype group. Total RNA (20 mg) was separated on 0.9% agarose gels containing 7% formaldehyde and blotted onto Hybond-N + (GE Healthcare). Hybridization proceeded at 428C for 24 h, and then bands were visualized by autoradiography using Fuji Imaging Plates (Fujifilm). All northern blot experiments were repeated at least three times using different sets of samples.
Western blot analysis
Mouse skeletal muscles were homogenized in 10 volumes (w/v) of a buffer comprising 50 mM Tris -HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 5 mM b-mercaptoethanol, 0.1 mM PMSF and 1 mM benzamidine. Crude muscle homogenates were separated by SDS-PAGE (3 -20% linear acrylamide gradient) and transferred to polyvinylidene difluoride membranes. Antibodies were purchased from the indicated sources: goat polyclonal anti-GRP78 (Santa Cruz Biotechnology), mouse monoclonal anti-eIF2a (Abcam), rabbit polyclonal anti-Ser51 phosphorylated eIF2a (Abcam), rabbit polyclonal anti-caveolin-1 (BD Transduction Laboratories), mouse monoclonal anti-caveolin-2 (BD Transduction Laboratories) and rabbit polyclonal anti-caveolin-3 (Alexis Corporation). All western blot experiments were repeated at least five times, with different sets of samples. Immunoblot band intensities were standardized with Coomassie blue staining of myosin heavy chain in each sample and analyzed using Multi Gauge version 2.2 software (Fujifilm).
